Erratum: Hydromorphone prescription for pain in children—What place in clinical practice?

Erratum: Hydromorphone prescription for pain in children—What place in clinical practice?

Bibliographic Details
Main Author:	Frontiers Production Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Pediatrics
Subjects:	hydromorphone opioids children safety pain
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2023.1186148/full

Similar Items

Hydromorphone Prescription for Pain in Children—What Place in Clinical Practice?
by: Frédérique Rodieux, et al.
Published: (2022-04-01)

Efficacy and safety of hydromorphone for cancer pain: a systematic review and meta-analysis
by: Mohammadreza Alinejadfard, et al.
Published: (2024-08-01)

Pharmacokinetics of a continuous intravenous infusion of hydromorphone in healthy dogs
by: Candace Wimbish, et al.
Published: (2024-04-01)

Use of oral osmotic hydromorphone in opioid switch for cancer pain
by: Rosa Palomba, et al.
Published: (2008-09-01)

The Application of Hydromorphone Combined with Low-dose Promethazine in Elderly Patients with End-stage Cancer Pain
by: Yang Ying, et al.
Published: (2024-11-01)

Patient-Controlled Subcutaneous Analgesia with Hydromorphone versus Oral Oxycontin for Opioid Titration of Cancer Pain: A Prospective Multicenter Randomized Trial
by: Xiao X, et al.
Published: (2024-04-01)

Comparison of continuous subcutaneous hydromorphone hydrochloride and morphine hydrochloride injection on skin disorders incidence: a retrospective study
by: Rei Tanaka, et al.
Published: (2024-12-01)

Two orthorhombic polymorphs of hydromorphone
by: Jaroslaw Mazurek, et al.
Published: (2016-05-01)

Hydromorphone reduced the incidence of emergence agitation after adenotonsillectomy in children with obstructive sleep apnea: A randomized, double-blind study
by: Huang Qiyuan, et al.
Published: (2025-02-01)

Epidural injection of hydromorphone for postoperative pain after episiotomy: a randomized controlled trial
by: Yixing Lu, et al.
Published: (2024-10-01)

Evaluating the antagonist effect of naltrexone implant via opioid challenge tests with escalating doses of hydromorphone injection in former heroin dependent patients
by: Wei Qu, et al.
Published: (2025-01-01)

Recent trends in opioid prescriptions in Korea from 2002 to 2015 based on the Korean NHIS-NSC cohort
by: Joungyoun Kim, et al.
Published: (2022-02-01)

A randomized, double-blind study of hydromorphone hydrochloride extended-release tablets versus oxycodone hydrochloride extended-release tablets for cancer pain: efficacy and safety in Japanese cancer patients (EXHEAL: a Phase III study of EXtended-release HydromorphonE for cAncer pain reLief)
by: Inoue S, et al.
Published: (2017-08-01)

Antitumor Effects of Hydromorphone on Human Gastric Cancer Cells in vitro
by: Liang B, et al.
Published: (2023-04-01)

Curative Effect of Patient-controlled Intravenous Analgesia with Hydromorphone, Sufentanil or Morphine in Treatment of Refractory Cancer Pain with Dysphagia
by: ZENG Yuan, WANG Guohua, YANG Yong
Published: (2022-12-01)

Antitumor Effects of Hydromorphone on Human Gastric Cancer Cells in vitro [Retraction]
by: Liang B, et al.
Published: (2024-07-01)

Use of clinical phenotypes to characterize emergency department patients administered intravenous opioids for acute pain
by: Mordechai Caplan, et al.
Published: (2023-09-01)

Effect of Methadone or Hydromorphone on Cardiac Conductivity in Dogs Before and During Sevoflurane Anesthesia
by: Stephanie Keating, et al.
Published: (2020-09-01)

Analgesic efficacy of hydromorphone in American alligators (Alligator mississippiensis)
by: Scott E. Henke, et al.
Published: (2025-02-01)

Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment comparison methods
by: Joseph Biskupiak, et al.
Published: (2024-03-01)

Chirurgia ortopedica in regime di day-surgery. Valutazione del dolore post-operatorio con buprenorfina, ossicodone e idromorfone - Orthopaedic surgery in a day-surgery setting. Comparing postoperative pain relief obtained with buprenorphine, oxycodone and hydromorphone
by: Elisabetta Ercolani, et al.
Published: (2010-11-01)

Clinical Application of Different Doses of Hydromorphone Slow-Release Analgesia in Lumbar Fusion in Elderly Patients
by: Xianwei Jin, et al.
Published: (2024-07-01)

A Critical Review of the Pharmacokinetics and Pharmacodynamics of Opioid Medications Used in Avian Patients
by: Evelyn Aliansyah, et al.
Published: (2021-12-01)

Different doses of nalmefene combined with hydromorphone hydrochloride for postoperative analgesia after colorectal surgery: a randomized controlled study
by: Ye Wang, et al.
Published: (2024-01-01)

Stability of Fentanyl Citrate, Hydromorphone Hydrochloride, Ketamine Hydrochloride, Midazolam, Morphine Sulfate, and Pentobarbital Sodium in Polypropylene Syringes
by: Collin Anderson, et al.
Published: (2015-12-01)

Controlled-release hydromorphone and risk of infection in adults: a systematic review
by: Andrea C. Tricco, et al.
Published: (2023-04-01)

Recrudescence of Focal Stroke Symptoms During Pain Management with Hydromorphone
by: Joshua D. Bernstock, et al.
Published: (2016-03-01)

Intravenous patient-controlled analgesia: in vitro stability profiles of mixtures containing fentanyl, hydromorphone, oxycodone, nefopam, ondansetron, and ramosetron
by: Chung Hun Lee, et al.
Published: (2020-08-01)

A systematic review of the risk factors for clinical response to opioids for all-age patients with cancer-related pain and presentation of the paediatric STOP pain study
by: Ersilia Lucenteforte, et al.
Published: (2018-05-01)

The 50% effective dose of hydromorphone and morphine for epidural analgesia in the hemorrhoidectomy: a double-blind, sequential dose-finding study
by: Xianghua Cao, et al.
Published: (2024-01-01)

Safety and efficacy of intravenous hydromorphone patient-controlled analgesia versus intramuscular pethidine in acute pancreatitis: An open-label, randomized controlled trial
by: Zhiyao Chen, et al.
Published: (2022-08-01)

Effective Dose of Epidural Hydromorphone for Analgesia Following Caesarean Section in Using Modified Dixon Sequential Method
by: Liu QQ, et al.
Published: (2024-11-01)

The efficacy and safety of epidural morphine/hydromorphone in the treatment of intractable postherpetic neuralgia: A single-center, double-blinded, randomized controlled, prospective, and non-inferiority study
by: Sun Yiping, et al.
Published: (2022-12-01)

Pain management, prescription opioid mortality, and the CDC: is the devil in the data?
by: Schatman ME, et al.
Published: (2017-10-01)

Erratum: Agonists Specific for κ-Opioid Receptor Induces Apoptosis of HCC Cells Through Enhanced Endoplasmic Reticulum Stress
by: Frontiers Production Office
Published: (2022-05-01)

Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot Study
by: Dobischok S, et al.
Published: (2022-12-01)

A Commentary on “Effective Dose of Epidural Hydromorphone for Analgesia Following Caesarean Section in Using Modified Dixon Sequential Method” [Letter]
by: Wu S, et al.
Published: (2024-12-01)

Changes in daily dose in open-label compared to double-blind: The role of clients’ expectations in injectable opioid agonist treatment
by: Sarin Blawatt, et al.
Published: (2023-06-01)

Assessing the risks of abuse of opioids in real-world data
by: M. V. Pchelintsev
Published: (2023-03-01)

Utilizing resources of neuropsychopharmacology to address the opioid overdose crisis
by: Anthony G. Phillips, et al.
Published: (2018-09-01)